Fiona Mei Wen Wu

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Aspects of urinary tract infections and antimicrobial resistance in hospitalized urology patients in Asia: 10-Year results of the Global Prevalence Study of Infections in Urology (GPIU)

Hyun‐Sop Choe, Seung‐Ju Lee, Yong‐Hyun Cho et al. · Journal of Infection and Chemotherapy · 2017 · 60 citations · Full text

Urinary Tract Infections, Urology, Antibiotics +9

High R.E.N.A.L. Nephrometry Scores Are Associated with Pathologic Upstaging of Clinical T ₁ Renal-Cell Carcinomas in Radical Nephrectomy Specimens: Implications for Nephron-Sparing Surgery

Melissa Tay, Thomas Paulraj Thamboo, Fiona Mei Wen Wu et al. · Journal of Endourology · 2014 · 41 citations

Impact of Kidney Disease Outcomes Quality Initiative Guidelines on the Prevalence of Chronic Kidney Disease After Living Donor Nephrectomy

Lincoln Tan, Bee Choo Tai, Fiona Mei Wen Wu et al. · The Journal of Urology · 2011 · 20 citations